Bacterial infection Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Bacterial infection clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 37 trials

Recruiting

Febrile Infants Swedish Study

Serious Bacterial InfectionSepsisBacteremia+4 more
Region Skane2,000 enrolled11 locationsNCT07134751
Recruiting
Not Applicable

Identification of Clinical, Genetic and Immunological Factors Involved in the Development of Severe Bacterial Infections in Pediatrics

Severe Bacterial Infections
Nantes University Hospital1,401 enrolled6 locationsNCT07111793
Recruiting

Changes Associated With H. Pylori and Gastric Carcinogenesis

Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Weill Medical College of Cornell University120 enrolled1 locationNCT02164409
Recruiting
Phase 2

A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)

Gram-negative Bacterial Infection
Pfizer48 enrolled30 locationsNCT06462235
Recruiting
Phase 4

Different Administration Regimens of CAZ-AVI in Combination With ATM for the Treatment of CR-GNB

Ceftazidime-avibactamAztreonamGram-negative Bacterial Infection+2 more
Jing Zhou144 enrolled1 locationNCT07478484
Recruiting
Phase 3

A Study to Evaluate the Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine (PCV13i) in Healthy Infants Aged 2 Months (Minimum 6 Weeks)

Bacterial InfectionsPneumococcal InfectionsStreptococcal Infections
CanSino Biologics Inc.600 enrolled3 locationsNCT07017777
Recruiting
Phase 2

Phase 2a Multiple Ascending Dose Study in Hospitalized Patients With Pneumonia.

PneumoniaRespiratory InfectionAcute Respiratory Distress Syndrome+3 more
Vasomune Therapeutics, Inc.120 enrolled5 locationsNCT05123755
Recruiting
Not Applicable

Healthrelated Quality of Life and Experiences of a Heart Rehabilitation Programme After Care for Infective Endocarditis.

Patient ParticipationBacterial InfectionsInfective Endocarditis+1 more
Region Halland50 enrolled1 locationNCT06704048
Recruiting
Phase 1

[18F]Fluoropropyl-Trimethoprim ([18F]F-TMP) PET/CT Imaging to Evaluate Biodistribution and Kinetics in Human Subjects

Bacterial Infections
University of Pennsylvania20 enrolled1 locationNCT04263792
Recruiting
Phase 2Phase 3

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Neonatal SepsisPneumoniaInfections+6 more
Minervax ApS338 enrolled6 locationsNCT06592586
Recruiting
Not Applicable

Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract

Viral InfectionMicrobial ColonizationOral Bacterial Infection+1 more
University of California, Irvine200 enrolled1 locationNCT05603650
Recruiting
Phase 3

A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

Bacterial InfectionsHypogammaglobulinemia
Grifols Therapeutics LLC386 enrolled61 locationsNCT05645107
Recruiting
Phase 1

A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal Impairment

Bacterial Infections
Qpex Biopharma, Inc.40 enrolled2 locationsNCT07104162
Recruiting
Phase 2

PMT for MDRO Decolonization

Enterobacteriaceae InfectionsMultidrug Resistant Bacterial Infection
University of Pennsylvania150 enrolled3 locationsNCT05632315
Recruiting
Phase 1

Phase I Study of Single/Multiple Ascending Doses of JKN2501 for Injection in Chinese Healthy Volunteers

Bacterial InfectionsRespiratory Tract InfectionsUrinary Tract Infections+1 more
Joincare Pharmaceutical Group Industry Co., Ltd66 enrolled1 locationNCT07207291
Recruiting
Not Applicable

Efficacy of A Novel RinSe Device to Reduce Oral Bacteria in Intubated IntEnsive CaRe Patients: a Pilot Study

Mechanical Ventilation ComplicationOral Bacterial Infection
The Cleveland Clinic21 enrolled1 locationNCT06193512
Recruiting
Phase 4

Cefiderocol and Ampicillin-sulbactam vs. Colistin +/- Meropenem for Carbapenem Resistant A. Baumannii

Carbapenem Resistant Bacterial InfectionAcinetobacter BacteremiaAcinetobacter Pneumonia
Rambam Health Care Campus734 enrolled3 locationsNCT05922124
Recruiting
Phase 4

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Enterobacteriaceae InfectionsBacteremiaBeta Lactam Resistant Bacterial Infection
Rambam Health Care Campus1,084 enrolled14 locationsNCT03671967
Recruiting
Phase 2

Clinical Trial to Study the Efficacy and Safety of Fluorothiazinone (N.F. Gamaleya NRCEM) in Prophylaxis of Nosocomial Bacterial Infections With Participation of Patients on MV

Gram Negative PneumoniaGram-Negative Bacterial InfectionsBacteremia Caused by Gram-Negative Bacteria
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation234 enrolled2 locationsNCT06135350
Recruiting
Not Applicable

Clean Trial - Chlorination to Reduce Enteric and Antibiotic Resistant Infections in Neonates

Serious Bacterial InfectionSepsisAntibiotic Resistant Infection+2 more
University of California, Berkeley45,450 enrolled2 locationsNCT06824350